Greystar buys Greenford site for giant PRS scheme
Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.
The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.
Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.
The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.
Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.
For entire article, click View More below.
The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.
Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.
The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.
Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.
For entire article, click View More below.
Media Resources
View our PRESS KITPress Release Archives
-
Ivanhoé Cambridge, Bouwinvest and Greystar Launch Paris Student and Young Professionals Accommodation Venture with €1 Billion Investment Capacity
-
Mexico Business: Multifamily Residences an Area of Opportunity
-
Greystar Acquires Property Management Business of Alliance Residential
-
Greystar Wins 2019 PERE Global Awards in Three Categories
-
Student Housing International: Europe and Latin America